DJIA 17,745.98 -5.41 -0.03%
NASDAQ 5,128.79 17.05 0.33%
S&P 500 2,108.63 0.06 0.00%
market minute promo

Novartis (NYSE: NVS)

company name or ticker
Company Photos
(Click to zoom)

Meet The Next Mega Blockbuster Heart Drug

Receptos Continues To Reward

Novartis (NVS) Stock Climbs, FDA Approves Heart Failure Drug

Premarket Biotech Digest: Oncolytics Bio, Depomed Acquisition Offer, Novartis' Entresto

European Stocks Recover as Greece Faces an Ultimatum

Novel Metastatic Risk-Based Technology Could Transform Cancer Treatment Protocol

Roof Leaker To Watch: Novartis (NVS)

Dr. Reddy's Laboratories Ltd (RDY) Ex-Dividend Date Scheduled for July 08, 2015

This Could Be Johnson & Johnson’s Future

As competition heats up for Johnson & Johnson's current blockbuster drugs like Zytiga and Remicade, we have to look into the pipeline to see what the future could hold.

Celgene: The Juno Therapeutics Deal Is Worth The Premium

See More Articles...